Dr. Cheah on Treatment for Nodular Lymphocyte Predominant Hodgkin Lymphoma

Chan Cheah, MD
Published Online: Saturday, Jun 17, 2017



Chan Cheah, MD, University of Western Australia, discusses treatment for patients with nodular lymphocyte predominant Hodgkin lymphoma.

Nodular lymphocyte predominant Hodgkin lymphoma is a rare subtype of Hodgkin lymphoma, Cheah states. This rare subtype has a tendency towards late relapse.

Previously nodular lymphocyte predominant Hodgkin lymphoma was treated with the same chemotherapy regimens as Hodgkin lymphoma. However, due to the biological differences superior outcomes might be achieved by using a non-Hodgkin lymphoma protocol, explains Cheah.
<<< More from the International Conference on Malignant Lymphoma


Chan Cheah, MD, University of Western Australia, discusses treatment for patients with nodular lymphocyte predominant Hodgkin lymphoma.

Nodular lymphocyte predominant Hodgkin lymphoma is a rare subtype of Hodgkin lymphoma, Cheah states. This rare subtype has a tendency towards late relapse.

Previously nodular lymphocyte predominant Hodgkin lymphoma was treated with the same chemotherapy regimens as Hodgkin lymphoma. However, due to the biological differences superior outcomes might be achieved by using a non-Hodgkin lymphoma protocol, explains Cheah.
<<< More from the International Conference on Malignant Lymphoma

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x